Literature DB >> 20699281

MyD88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice.

Teri L Kissner1, Gordon Ruthel, Emily D Cisney, Robert G Ulrich, Stefan Fernandez, Kamal U Saikh.   

Abstract

An elevated pro-inflammatory cytokine response is the primary cause of death by toxic shock after exposure to staphylococcal enterotoxin B (SEB). Identifying an intracellular signal mediator that predominantly controls the pro-inflammatory response is important for developing a therapeutic strategy. We examined the role of the signaling adaptor MyD88 in cell culture and in a mouse model of toxic shock. Our results indicated that elevated tumor necrosis factor-α, interferon-γ, interleukin (IL)-1α/β and IL-6 production from mouse spleen cells treated with SEB alone or in combination with lipopolysaccharide (LPS) was regulated by MyD88. Elevated levels of MyD88 protein in spleen cells, as well as in CD11c(+) or Mac3(+) cells, and activation of nuclear factor-κB in spleen cells were observed in mice treated with SEB. An SEB-dose dependent lethality was observed in LPS-potentiated and in D-galactosamine-sensitized mice. D-Galactosamine treatment of spleen cells had no effect in cytokine induction but rather increased the sensitivity to toxic shock in mice. Our results demonstrated an impaired pro-inflammatory cytokine production by spleen cells of MyD88(-/-) mice in response to SEB or SEB plus LPS. Most importantly, MyD88(-/-) mice were resistant to SEB-induced death. These results demonstrate that MyD88-dependent pro-inflammatory signaling is responsible for SEB intoxication. In addition, our studies also demonstrated that LPS potentiation, in comparison to D-galactosamine sensitization, contributes to a stronger SEB-induced lethality. This is due to the pro-inflammatory cytokine response elicited by MyD88 after exposure to SEB and LPS. These findings offer an important insight upon SEB intoxication and subsequent therapy targeting MyD88.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20699281     DOI: 10.1177/1753425910374092

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  11 in total

1.  A small molecule that mimics the BB-loop in the Toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced pro-inflammatory cytokine production and toxicity in mice.

Authors:  Teri L Kissner; Lionel Moisan; Enrique Mann; Shahabuddin Alam; Gordon Ruthel; Robert G Ulrich; Mitra Rebek; Julius Rebek; Kamal U Saikh
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

2.  ΔPK oncolytic activity includes modulation of the tumour cell milieu.

Authors:  Dominique Bollino; Aric Colunga; Baiquan Li; Laure Aurelian
Journal:  J Gen Virol       Date:  2015-11-24       Impact factor: 3.891

3.  Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules.

Authors:  Teri L Kissner; Gordon Ruthel; Shahabuddin Alam; Robert G Ulrich; Stefan Fernandez; Kamal U Saikh
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

4.  Intracerebral overexpression of miR-669c is protective in mouse ischemic stroke model by targeting MyD88 and inducing alternative microglial/macrophage activation.

Authors:  Natalia Kolosowska; Maria Gotkiewicz; Hiramani Dhungana; Luca Giudice; Rosalba Giugno; Daphne Box; Mikko T Huuskonen; Paula Korhonen; Flavia Scoyni; Katja M Kanninen; Seppo Ylä-Herttuala; Tiia A Turunen; Mikko P Turunen; Jari Koistinaho; Tarja Malm
Journal:  J Neuroinflammation       Date:  2020-06-19       Impact factor: 8.322

Review 5.  Exploring the Role of Staphylococcus Aureus Toxins in Atopic Dermatitis.

Authors:  Fabio Seiti Yamada Yoshikawa; Josenilson Feitosa de Lima; Maria Notomi Sato; Yasmin Álefe Leuzzi Ramos; Valeria Aoki; Raquel Leao Orfali
Journal:  Toxins (Basel)       Date:  2019-06-05       Impact factor: 4.546

6.  Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression.

Authors:  Vincenzo Quagliariello; Massimiliano Berretta; Simona Buccolo; Martina Iovine; Andrea Paccone; Ernesta Cavalcanti; Rosaria Taibi; Monica Montopoli; Gerardo Botti; Nicola Maurea
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

7.  Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88.

Authors:  Teri L Kissner; Gordon Ruthel; Shahabuddin Alam; Enrique Mann; Dariush Ajami; Mitra Rebek; Eileen Larkin; Stefan Fernandez; Robert G Ulrich; Sun Ping; David S Waugh; Julius Rebek; Kamal U Saikh
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

8.  Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease.

Authors:  Der-Yuan Chen; Chi-Chen Lin; Yi-Ming Chen; Joung-Liang Lan; Wei-Ting Hung; Hsin-Hua Chen; Kuo-Lung Lai; Chia-Wei Hsieh
Journal:  Arthritis Res Ther       Date:  2013-03-04       Impact factor: 5.156

9.  Discovery of small molecule inhibitors of MyD88-dependent signaling pathways using a computational screen.

Authors:  Mark A Olson; Michael S Lee; Teri L Kissner; Shahabuddin Alam; David S Waugh; Kamal U Saikh
Journal:  Sci Rep       Date:  2015-09-18       Impact factor: 4.379

10.  Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling.

Authors:  Colin J Suckling; Shahabuddin Alam; Mark A Olson; Kamal U Saikh; Margaret M Harnett; William Harnett
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.